Rwanda secures $3.6m from EU to revamp labs for Covid jab production
Rwanda plans to start manufacturing coronavirus vaccines using mRNA technology after it secured international backing to build local capacity in the coming months. PHOTO | FILE | NMG
Rwanda has signed a Rwf3.6 billion ($3.6 million) partnership with the European Union to help upgrade the country’s laboratory capacity to help it attract investors to manufacture Covid-19 vaccines.
The funds will be used to strengthen the Foods and Drugs Authority's quality control for medical products, to enable the regulator acquire necessary certification from the World Health Organisation (WHO).
